AAO 2024 Subspecialty Day Update: Neovascular AMD
Some of the top names in retina, from Dr. Judy Kim (USA) to Prof. Gemmy Cheung (Singapore), gave updates on…
Sandoz’s Anti-VEGF Biosimilar Secures FDA Approval for nAMD Treatment
On August 12, 2024, Sandoz (Basel, Switzerland), a generic and biosimilar pharmaceuticals company, has received FDA approval for Enzeevu™ (aflibercept-abzv,…
popular posts
latest posts